WHO ICTRP trial

Comparison of hospitalization time of patients with different treatments of…

IRCT20210830052333N1 · Iranian Registry of Clinical Trials (IRCT) · Recruiting

Key facts

Trial ID IRCT20210830052333N1
Public title Comparison of hospitalization time of patients with different treatments of deoulin nebulizer, deoulin nebulizer with inhalation spray and deoulin nebulizer and pulmicort simultaneously in patients with chronic obstructive pulmonary disease
Scientific title Comparison of hospitalization time with deoulin nebulizer, deoulin nebulizer with inhalation spray and deoulin nebulizer and pulmicort simultaneously in patients with chronic obstructive pulmonary disease in the disease exacerbation stage
Primary sponsor Shahroud University of Medical Sciences
Registry Iranian Registry of Clinical Trials (IRCT)
Recruitment status Recruiting
Study type interventional
Phase 2-3
Countries Iran (Islamic Republic of)
Conditions Chronic obstructive pulmonary disease. Chronic obstructive pulmonary disease with (acute) exacerbation;J44.1
Interventions Intervention 1: Intervention group 1: For the first intervention group, in addition to routine treatments including oxygen therapy, deoulin nebulization (salbutamol + ipratropium bromide) in a 2.5 ml vial every 20 minutes once to three…
Registration date Oct 13, 2021
Target size 174
Registry page irct.behdasht.gov.ir

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations